CS Paper Radar

Detecting Spin in Clinical Trials with Large Language Models

Tjaš Ajdovec, Marko Robnik-Šikonja, Simon Šuster

cs.CL ·submitted 2026-10-08 12:33 UTC · v1
publishedcode/data

Abstract

Spin in clinical trials includes reporting practices that distort the presentation of results. This is particularly critical in medicine, where spin is present in more than 50% of randomized controlled trials that fail to reach statistical significance. The comparison of primary and reported outcomes is crucial for detecting several types of spin, including outcome switching. We used 300 pairs of outcomes labeled with semantic similarity to develop a system for automatic detection of outcome switching. We evaluated baseline text similarity models and open-source LLMs using generated similarity scores and the Youden index to determine the classification threshold. The proposed approach involves prompt engineering, classification based on token probabilities, and majority voting for the final decision. The results on the test set of 2,496 examples with an F1 score of 0.78 and an accuracy of 0.90 outperform baseline text similarity models but trail behind fine-tuned versions of BERT. We used LLMs to generate natural language explanations for the classified instances and manually assessed their quality.

Comment
5 pages, 1 figure, 2 tables. Accepted at the 29th International Multiconference Information Society (IS 2026), AI in Healthcare track, Ljubljana, Slovenia. Code: https://github.com/ta5946/Spin
DOI
10.70314/is.2026.aihc.42

Closest papers

Nearest neighbours by meaning across the whole index.

Advancing Clinical Trial Outcome Prediction with Domain-Specific Large Language Models

cs.AI ·2026-10-30 ·Burak Bakkar, Hana Moalla, Mohamed Salem Jedidi, Haifa Ben Messaoud, Nicolas Lopez Carranza
benchmark similarity 0.70
Abstract

Clinical trial failures are a major barrier to efficient drug development, incurring substantial costs and delaying patient access to effective therapies. Structured approaches such as the Hierarchical Interaction Network (HINT) predict trial outcomes by explicitly modelling interactions between drugs, diseases and protocols, but make limited use of the free text in trial registrations. We evaluate two domain-specific language models, BioBERT (108M parameters) and BioMistral (7B parameters), for phase-level outcome prediction on the TOP benchmark (12,477 trials), representing each trial as text built from ten ClinicalTrials.gov fields. We compare fine-tuning (full fine-tuning for BioBERT, low-rank adaptation for BioMistral) with probing, in which the pretrained model is frozen and only a lightweight classifier is trained on its embeddings. On the held-out test set of each phase, all four language-model variants achieved higher ROC-AUC (0.613--0.772) and PR-AUC (0.649--0.901) than the published HINT results, corresponding to relative PR-AUC gains of 10--20\%. F1 differences were small and mixed, and no model, including HINT, clearly exceeded the F1 of a trivial classifier that predicts success for every trial. Under the configurations tested, probing performed comparably to fine-tuning: fine-tuned models scored highest on ROC-AUC and PR-AUC in Phases I and II, and frozen BioMistral embeddings in Phase III (ROC-AUC 0.772; PR-AUC 0.901), although most differences between variants were below 0.03 and were not tested for significance. These results suggest that pretrained biomedical representations already encode signal relevant to trial outcome, and that probing is a computationally cheaper alternative to fine-tuning for this task.

0.22

TrialJev: Open-Weight Single Pass Eligibility Scoring for Patient Trial Screening

cs.LG ·2026-11-06 ·Omar Ibrahim, Grant Hamblin, Benjamin Haibe-Kains
code/data similarity 0.67
Abstract · 38 pages. Code: https://github.com/oibrahi1/TrialJev. Models: https://huggingface.co/omareng/TrialJev

Clinical trial screening requires assessing large numbers of patient-trial pairs to prioritize candidates for detailed eligibility review, often under restrictions on sharing patient records. We introduce TrialJev, an open-weight eligibility scorer that uses LoRA-adapted Qwen models and a pointer head to score natural-language answer options in a single forward pass, without autoregressive decoding. Trained on TREC Clinical Trials 2021 and evaluated on 6,975 eligible-or-excluded pairs from 50 unseen TREC 2022 synthetic patients, TrialJev achieves 80.97% (Qwen3.5-27B) and 81.84% (Qwen3.8-27B) accuracy, compared with 79.87% and 79.93% for LLMs fine-tuned on the same data to generate verdicts. In matched batch-1 measurements, verdict generation takes 2.45-2.70 times as long as the one-pass inference of TrialJev at 9B-27B. Under a common development-fitted decision correction, the two 27B TrialJev models reach 80.99% and 81.88% accuracy, compared with 81.28% for the proprietary hosted Jev API; paired confidence intervals include zero. TrialJev runs locally on a single GPU, requiring approximately 178 ms per pair at 27B, without transmitting patient text to an external model API. An A/B-logit ablation shows that avoiding decoding, rather than the pointer head alone, accounts for the measured efficiency advantage. TrialJev is intended for first-pass prioritization of candidate trials, complementing rather than replacing explanatory models and clinical review. Evaluation is limited to synthetic patients and implementation-specific timing, and clinical use has not been validated. Adapters, pointer heads, and model cards are released on Hugging Face.

0.22

DiagTrace: An Interactive Benchmark for Clinical Decision Making

cs.CL cs.AI ·2026-11-16 ·Yufan Wang, Rui Yang, Yi Lin, Chunhua Weng, Yifan Peng
publishedbenchmark similarity 0.65
Abstract · Accepted to Findings of EACL 2027

Large language models (LLMs) have shown strong performance on medical question answering and diagnostic reasoning benchmarks. However, existing evaluations typically provide all patient information upfront and assess only the final diagnosis or rationale. This setup ignores the need to acquire diagnostic evidence incrementally from incomplete information in real-world diagnosis. To bridge this gap, we introduce DiagTrace, a source-grounded benchmark for evaluating whether LLMs can reconstruct the documented diagnostic trajectory through interactive information seeking. Each benchmark instance is built from a PubMed Central case report and includes an initial presentation, an event bank, a clinical course, and diagnostic references. DiagTrace contains 510 cases across eight specialties, with 225 used to evaluate four LLMs on clinical-course alignment, interaction quality, and efficiency. Results reveal trade-offs in coverage, source-consistent ordering, and turn use.

0.14

UniBuc at SemEval-2024 Task 2: Tailored Prompting with Solar for Clinical NLI

cs.CL ·2026-09-30 ·Marius Micluta-Campeanu, Claudiu Creanga, Ana-Maria Bucur, Ana Sabina Uban, Liviu P. Dinu
benchmark similarity 0.64
Abstract

This paper describes the approach of the UniBuc team in tackling the SemEval 2024 Task 2: Safe Biomedical Natural Language Inference for Clinical Trials. We used SOLAR Instruct, without any fine-tuning, while focusing on input manipulation and tailored prompting. By customizing prompts for individual CTR sections, in both zero-shot and few-shots settings, we managed to achieve a consistency score of 0.72, ranking 14th in the leaderboard. Our thorough error analysis revealed that our model has a tendency to take shortcuts and rely on simple heuristics, especially when dealing with semantic-preserving changes.

0.56

A primer on evaluation methods for large language models in healthcare

cs.CL cs.AI ·2026-09-13 ·Suzannah E McKinney, Phuc Vu, Samuel A Justice, Christopher Humphries, Alyssa Pradhan +8 more
similarity 0.64
Abstract

Large language models (LLMs) have a growing range of applications in medicine, and their evaluation is critical for ensuring they provide benefit and not harm. This evaluation can be more challenging than traditional machine learning for many reasons, including probabilistic and open-ended outputs, and behavior that shifts with prompt design and accumulated context. This review covers four key areas of LLM evaluation: principles of study design, statistical methods, capability evaluation and clinical application evaluation. Capability evaluation considers different benchmarks, including multiple-choice, agentic and multi-turn benchmarks, alongside operational metrics like token usage and latency. Clinical application evaluation addresses establishing accuracy of free text outputs, such as human review and LLM-as-a-judge, and clinical trial approaches. Across sections, we describe underlying concepts and potential pitfalls, while emphasizing the importance of aligning evaluation methods with the research question. Together, this article aims to provide a pragmatic basis for designing and executing rigorous evaluations of healthcare LLMs.

0.15

Clinical Domain Classification from Medical Transcriptions

cs.CL cs.LG ·2026-09-19 ·Sravani Pottipati, Lakshmikar R. Polamreddy
similarity 0.63
Abstract

Clinical domain classification plays an important role in organizing and analyzing large volumes of unstructured medical text. However, medical transcription datasets are often highly imbalanced, which can substantially degrade classification performance, particularly for underrepresented clinical specialties. In this work, we present a comparative study of machine learning and transformer-based approaches for clinical domain classification from medical transcriptions. We evaluate six traditional machine learning classifiers---Naive Bayes, Support Vector Machine (SVM), Decision Tree, Random Forest, K-Nearest Neighbors (KNN), and XGBoost---along with two pretrained transformer models, BERT and XLNet, and a few-shot large language model prompting approach. Experiments are conducted on medical transcription data collected from MTSamples, comprising 5,013 samples across 40 clinical specialties. To address severe class imbalance, we investigate two balancing strategies: text augmentation using NLP-based synonym replacement and Synthetic Minority Over-sampling Technique (SMOTE). Experimental results demonstrate that data balancing substantially improves classification performance across the evaluated models. In particular, BERT achieves the highest F1-score of 0.996 on the SMOTE-balanced dataset while requiring lower training time than XLNet. The results highlight the effectiveness of transformer-based representations combined with appropriate data balancing strategies for clinical domain classification and provide a systematic comparison of classical machine learning, transformer models, and few-shot prompting for medical transcription analysis.

0.13

Toward Better Assessment of LLMs' Performance in Clinical Error Detection

cs.CL cs.AIcs.LG ·2026-08-17 ·Yifan Zhang, Rahmatollah Beheshti
top venuebenchmarkcode/data similarity 0.63
Abstract · Accepted at Machine Learning for Healthcare (MLHC) 2026; to appear in Proceedings of Machine Learning Research (PMLR), Vol. 340

Automated detection of errors in clinical documentation is a promising application of large language models (LLMs), yet decisions to deploy such models rest on benchmarks that evaluate each clinical note in isolation. Error-detection benchmarks are typically constructed by injecting errors into notes, such that each erroneous note has a natural counterpart. Aggregate discriminative metrics (e.g., balanced accuracy or F1) do not exploit this structure. We show that this omission is consequential. In particular, evaluating 15 diverse LLMs on 4 standardized clinical error-detection test sets across 3 languages, we find that 13 of 15 models fall below the level of random pairwise discrimination, even while achieving F1 scores that standard practice would read as moderate. We also observe that the underlying bias patterns differ across languages: the same model can default to "no error" on one language and over-flag errors on another. To diagnose where discrimination breaks down, we further introduce a procedure to score the evidence models cite in their outputs. We find that while models consistently locate error-relevant content, they fail to produce the corresponding correct verdict on the clean counterpart. Finally, we show that F1 and pairwise accuracy are driven in opposite directions by the same underlying bias, so that ranking models by F1 may systematically promote the weakest discriminators. For safety-critical clinical NLP applications, we advocate for supplementing aggregate metrics with paired evaluations in benchmark reporting. Code and analysis scripts are available at https://github.com/healthylaife/paired-clinical-eval.

0.58

Defining and Categorising Human-AI Interactions in Clinical Trials: A Multidimensional Human-AI Classification Approach

cs.AI ·2026-09-29 ·Sandra Woolley, Tim Collins, Khalid Khattak, Illia Chernomorets, Ariane Arevalo +1 more
similarity 0.62
Abstract · 16 pages

This paper examines human-AI interactions (HAIIs) in clinical trials and presents a multidimensional categorisation framework that classifies interactions according to AI tasks, human-AI relationships, interaction configurations and interacting human groups. We define HAII, examine existing taxonomies and extend existing categorisation approaches through this novel multidimensional framework. We purposively sampled 15 clinical trials from a previously reported dataset. Each trial was independently categorised by two human reviewers and six large language model (LLM) classifiers. The proposed categorisation provides a structured method for the consistent identification, comparison and synthesis of human-AI interactions across clinical-trial records. The framework is intended to support more consistent comparison and synthesis of AI-related clinical trials and to make explicit the different forms of human involvement associated with AI interventions. The results demonstrate the potential for LLM-assisted categorisation while indicating the continuing importance of human judgement where trial records are incomplete or ambiguous. The principal contribution is a proposed multidimensional framework that brings together AI tasks, human-AI relationships, interaction configurations and interacting human groups within a single approach designed for clinical-trial records. Its significance lies in its potential to support more systematic identification, comparison and synthesis of how humans and AI interact in clinical trials.

0.22